DE68918391T2 - Okulare hypotensive Mittel. - Google Patents

Okulare hypotensive Mittel.

Info

Publication number
DE68918391T2
DE68918391T2 DE68918391T DE68918391T DE68918391T2 DE 68918391 T2 DE68918391 T2 DE 68918391T2 DE 68918391 T DE68918391 T DE 68918391T DE 68918391 T DE68918391 T DE 68918391T DE 68918391 T2 DE68918391 T2 DE 68918391T2
Authority
DE
Germany
Prior art keywords
group
pgs
use according
hydrocarbon
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68918391T
Other languages
German (de)
English (en)
Other versions
DE68918391D1 (de
Inventor
Tomio Oda
Ryuji Ueno
Ryuzo Ueno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ueno Seiyaku Oyo Kenkyujo KK
R Tech Ueno Ltd
Original Assignee
Ueno Seiyaku Oyo Kenkyujo KK
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP24872188A external-priority patent/JPH0739344B2/ja
Priority claimed from JP24872088A external-priority patent/JPH0739343B2/ja
Application filed by Ueno Seiyaku Oyo Kenkyujo KK, R Tech Ueno Ltd filed Critical Ueno Seiyaku Oyo Kenkyujo KK
Application granted granted Critical
Publication of DE68918391D1 publication Critical patent/DE68918391D1/de
Publication of DE68918391T2 publication Critical patent/DE68918391T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Endoscopes (AREA)
DE68918391T 1988-10-01 1989-09-29 Okulare hypotensive Mittel. Expired - Fee Related DE68918391T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24872188A JPH0739344B2 (ja) 1988-10-01 1988-10-01 眼圧降下剤
JP24872088A JPH0739343B2 (ja) 1988-10-01 1988-10-01 眼圧降下剤

Publications (2)

Publication Number Publication Date
DE68918391D1 DE68918391D1 (de) 1994-10-27
DE68918391T2 true DE68918391T2 (de) 1995-01-19

Family

ID=26538919

Family Applications (2)

Application Number Title Priority Date Filing Date
DE68918391T Expired - Fee Related DE68918391T2 (de) 1988-10-01 1989-09-29 Okulare hypotensive Mittel.
DE68928551T Expired - Fee Related DE68928551T2 (de) 1988-10-01 1989-09-29 Oculare hypotensive Mittel

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE68928551T Expired - Fee Related DE68928551T2 (de) 1988-10-01 1989-09-29 Oculare hypotensive Mittel

Country Status (3)

Country Link
EP (2) EP0366279B1 (https=)
AT (2) ATE111736T1 (https=)
DE (2) DE68918391T2 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187813B1 (en) 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
EP1300149A3 (en) * 1988-09-06 2003-05-14 Pharmacia Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5296504A (en) * 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5321128A (en) * 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
WO1990002553A1 (en) * 1988-09-06 1990-03-22 Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
TW224942B (https=) * 1990-04-04 1994-06-11 Adka Ueno Kk
EP0458588B1 (en) * 1990-05-22 1994-11-30 R-Tech Ueno Ltd. Treatment of ocular hypertension with a synergistic combination for ocular administration
ATE117208T1 (de) * 1990-05-22 1995-02-15 R Tech Ueno Ltd Behandlung von intraokularem druck mit einer ophthalmischen synergistischen kombination.
DK0458590T3 (da) * 1990-05-22 1996-02-05 R Tech Ueno Ltd Behandling af okulær hypertension med en synergistisk konbination
TW210287B (https=) * 1991-03-01 1993-08-01 Kabushikaisha Ueno Seiyaku Oyo Kenkyujo
ATE153855T1 (de) * 1992-10-13 1997-06-15 Alcon Lab Inc Zusammensetzungen zur behandlung von glaukoma die prostaglandine und clonidinderivate enthalten
US5510383A (en) * 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
US6184250B1 (en) 1993-08-03 2001-02-06 Alcon Laboratories, Inc. Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension
US6294563B1 (en) 1994-10-27 2001-09-25 Allergan Sales, Inc. Combinations of prostaglandins and brimonidine or derivatives thereof
AU5258698A (en) * 1996-11-12 1998-06-03 Alcon Laboratories, Inc. 15-ketal prostaglandins for the treatment of glaucoma or ocular hypertension
SE9900672D0 (sv) 1999-02-25 1999-02-25 Synphora Ab Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula
US20020035148A1 (en) * 2000-07-20 2002-03-21 Ryuji Ueno Treatment of ocular hypertension
MXPA04000980A (es) * 2001-07-31 2004-04-20 Sucampo Ag Tratamiento de hipertension ocular y glaucoma.
WO2003018025A1 (en) * 2001-08-23 2003-03-06 Sucampo Ag Method and composition for treatment of ocular hypertension and glaucoma
WO2003082257A2 (en) * 2002-03-28 2003-10-09 Sucampo Ag Method for treating ocular hypertension and glaucoma

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1356581A (en) * 1970-10-09 1974-06-12 Ici Ltd Cyclopentane derivatives
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
US4824857A (en) * 1986-05-16 1989-04-25 Yasumasa Goh Use of prostaglandin D2 -active substances
JPH0762626B2 (ja) * 1987-06-23 1995-07-05 株式会社大洋バルブ製作所 流量検出器
ES2052735T3 (es) * 1987-09-18 1994-07-16 R Tech Ueno Ltd Un metodo para producir un agente hipotensor ocular.
JP2597629B2 (ja) * 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化

Also Published As

Publication number Publication date
EP0366279A3 (en) 1991-12-27
DE68928551D1 (de) 1998-02-19
ATE111736T1 (de) 1994-10-15
DE68928551T2 (de) 1998-04-23
EP0366279B1 (en) 1994-09-21
EP0580268B1 (en) 1998-01-14
EP0580268A2 (en) 1994-01-26
EP0580268A3 (https=) 1994-02-23
DE68918391D1 (de) 1994-10-27
EP0366279A2 (en) 1990-05-02
ATE162074T1 (de) 1998-01-15

Similar Documents

Publication Publication Date Title
DE3850676T2 (de) Hypotensive okulare Mittel.
DE68918391T2 (de) Okulare hypotensive Mittel.
DE69129921T2 (de) Behandlung von Katarakt mit 15-keto-Prostaglandinderivaten
DE69418214T2 (de) Cyclopentan(penten)-hepten-oder heptansäuren und deren derivate als therapeutische wirkstoffe
DE69434228T2 (de) Verwendung von Fluprostenolisopropylester zur Herstellung eines Arzneimittels zur Behandlung von Glaukom und okularer Hypertension
DE69714023T2 (de) Cyclopentane heptan(ene)säure, 2-heteroarylalkenylderivate als therapeutisches mittel
US5194429A (en) Ocular hypotensive agents
DE69232150T2 (de) Behandlung von Augenhochdruck mit Betablockern und Prostansäurederivaten
DE69511181T2 (de) Mittel für Behandlung der Leber-Gallenerkrankungen
DE69613693T2 (de) 2-heteroarylalkenylderivate der cyclopentano-heptan(heptaen)säure als therapeutisches mittel zur behandlung des erhöhten augeninnendruckes
DE3873007T2 (de) Kathartica.
DE68905241T2 (de) Tracheobronchodilatator.
DE69105349T2 (de) Behandlung von intraocularem Druck mit einer synergistischen Kombination zur ophthalmischen Verwendung.
DE69118978T2 (de) Behandlung von entzündlichen Erkrankungen mit 15-Ketoprostaglandinen
DE68908950T2 (de) Anwendung von 15-Keto-prostaglandin-E- oder F-Verbindungen für uterine Kontraktionen.
DE69430538T2 (de) 2-azylalkyl-oder arylalenyl-cyclopentanheptan-und heptensäuren, derivate und therapeutische anwendung
DE69116224T2 (de) Behandlung von intraokularem Druck mit einer synergischen Kombination
DE69106777T2 (de) Behandlung von intraokularem Druck mit einer ophthalmischen synergistischen Kombination.
DE69024744T2 (de) Behandlung der hepatobilären Erkrankung mit 15-Ketoprostaglandin-Derivaten
US5236907A (en) Ocular hypotensive agents
DE69032000T2 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
DE69100171T2 (de) Synergistische Kombination zur ophthalmischen Verwendung.
DE69417584T2 (de) 7-[carboxyalkyl oder alkenyl]-6-[alkyl oder alkenyl] 3-oxo-2,4-dioxobicyclo-[3.2.1]octan und dessen derivate
CH638510A5 (de) Prostacyclinanaloga.
DE69023459T2 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee